Exelixis (EXEL) Cash & Equivalents (2010 - 2026)
Exelixis (EXEL) recorded Cash & Equivalents of $281.45 million in Q2 2027, up 71.2% from $164.43 million a year earlier and up 24.5% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2026, Exelixis reported Cash & Equivalents of $482.49 million, up 122.0% from FY2025.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -5.7% (FY2021 to FY2026).
- Across earlier years, Cash & Equivalents came in at $217.37 million in FY2025, $262.99 million in FY2023 (-47.5%) and $501.2 million in FY2022 (-22.6%).
- Quarterly Cash & Equivalents has ranged from $164.43 million in Q2 2026 to $482.49 million in Q4 2026 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 35.9% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $226.15 million (Q1 2027), $482.49 million (Q4 2026) and $376.3 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Exelixis | 14.53 Bn | 10.87 Bn | 608.03 Mn | 281.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 281.45 Mn |
| Apr 3, 2026 | 226.15 Mn |
| Jan 2, 2026 | 482.49 Mn |
| Oct 3, 2025 | 376.30 Mn |
| Jul 4, 2025 | 164.43 Mn |
| Apr 4, 2025 | 183.75 Mn |
| Jan 3, 2025 | 217.37 Mn |
| Sep 27, 2024 | 258.35 Mn |
| Jun 28, 2024 | 198.46 Mn |
| Mar 29, 2024 | 259.56 Mn |
| Dec 29, 2023 | 262.99 Mn |
| Sep 29, 2023 | 396.86 Mn |
| Jun 30, 2023 | 464.48 Mn |
| Mar 31, 2023 | 540.60 Mn |
| Dec 30, 2022 | 501.20 Mn |
| Sep 30, 2022 | 675.29 Mn |
| Jul 1, 2022 | 627.00 Mn |
| Apr 1, 2022 | 723.27 Mn |
| Dec 31, 2021 | 647.17 Mn |
| Oct 1, 2021 | 567.33 Mn |
API Access
Exelixis Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();